Navigation Links
Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
Date:1/10/2013

2011Net sales

$   3,007,000

$ 4,017,000Cost of sales

1,974,000

2,770,000Gross profit

1,033,000

1,247,000Operating expenses:Selling expenses

322,000

369,000General and administrative expenses

627,000

688,000Research and development costs

464,000

508,000Total operating expenses

1,413,000

1,565,000Loss from continuing operations before items below

(380,000)

(318,000)Other expense:Interest expense

--

(10,000)Total other expense

--

(10,000)Loss from continuing operations before provision for (benefit from) income taxes

(380,000)

(328,000)Provision for (benefit from) income taxes

(16,000)

1,000Loss from continuing operations

(364,000)

(329,000)Income from discontinued operations, net of provision for income taxes of $21,000 in 2012 and $0 in 2011

16,000

37,000Net loss

$
(348,000)

$ (292,000)Per share data:Loss from continuing operationsBasic

$
(0.11)

$
(0.10)Diluted

$
(0.11)

$
(0.10)Income from discontinued operationsBasic

$
--

$
.01Diluted

$
--

$
.01Net lossBasic

$
(0.11)

$
(0.09)Diluted

$
(0.11)

$
(0.09)Weighted average shares outstanding - basic

3,319,180

3,272,350Weighted average shares outstanding - diluted

3,319,180

3,272,350 

 

PRO-DEX, INC. and SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS For The Six Months Ended December 31,2012

2011Net sales

$   6,468,000

$  9,062,000Cost of sales

4,199,000

5,707,000Gross profit

2,269,000

3,355,000Operating expenses:Selling expenses

'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
2. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
3. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Announces Update Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
6. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
7. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
8. Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
9. Accelr8 Announces Results of 2012 Annual Meeting
10. OncoSec Medical Announces $7.2 Million Public Offering
11. Isis Announces That ISIS-TTR Rx Was Granted Fast Track Designation For The Treatment Of Patients With FAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 Sequent Medical, ... for the SL ("Single Layer") family of WEB ® ... release of these new models in select neurovascular centers ... and superior navigability that will enable physicians to treat ... The SL configurations are made possible by ...
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... 20, 2013 Enrollment of patients with Type ... dose-finding clinical trial of product candidate NewMet ™, ... for Type 2 diabetes. Elcelyx expects to complete enrollment ... June. Results of the trial,s primary endpoint of change ... and the read-out for long-term glucose lowering and weight ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4
... Karyopharm Therapeutics Inc., a leader in the new field of ... nuclear transport machinery plays an integral role in the regulation of ... disease. Karyopharm is focused on the discovery and development of novel ... n uclear e xport (SINE) ...
... CLEVELAND, Nov. 3, 2010 From pill-sized cameras to radioactive ... Clinic,s Top 10 Medical Innovations for 2011 showcases new techniques, ... The list of breakthrough devices and therapies was selected ... unveiled during Cleveland Clinic,s 2010 Medical Innovation Summit. ...
Cached Medicine Technology:Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders 2Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders 3Cleveland Clinic Unveils Top 10 Medical Innovations for 2011 2Cleveland Clinic Unveils Top 10 Medical Innovations for 2011 3Cleveland Clinic Unveils Top 10 Medical Innovations for 2011 4
(Date:5/20/2013)... May 20, 2013 yurbuds®, maker of ... out, today announced the launch of its new Signature ... Series-Pete Jacobs, with more signature athletes to come. Created ... Signature Series ITE 100 is the perfect training partner ... ITE 100 features reflective, tangle-resistant Kevlar cords, premium sound ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...
(Date:5/20/2013)... WINSTON-SALEM, N.C. May 20, 2013 Nearly 20 ... in the U.S. are refused for transplant due to ... the kidney,s filtering units to the organ going too ... of being discarded, these organs could be "recycled" to ... Researchers at Wake Forest Baptist Medical Center and colleagues, ...
(Date:5/20/2013)... Amsterdam, NL, 20 May 2013 While Huntington,s ... community anticipates that new disease-modifying therapies in development ... success of HD research depends upon the identification ... and evaluate therapies, and these biomarkers may eventually ... Biomarkers could be especially helpful to monitor changes ...
(Date:5/20/2013)... Dorland Health, a division of ... annual Case In Point Platinum Awards, recognizing outstanding ... the system is patient- and family-centric, safe and ... creative work across the healthcare system that is ... of care through effective care coordination across the ...
Breaking Medicine News(10 mins):Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Study suggests new source of kidneys for transplant 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
... Bill to Protect Patient Access WASHINGTON, April 3 ... testing and reduce the physical and economic burden of ... Fracture Prevention and Osteoporosis Testing Act of 2009," (S. ... Olympia Snowe (R-ME) introduced the Senate version and Representatives ...
... IP - Over $2,200 In Donations Raised to ... photographer and philanthropist is taking his personal experience ... raise awareness for the nonprofit Innocence Project ... Mr. Verger for using his considerable talents to ...
... Don Jones, President of the California Association ... California Congressional Delegation today to join him in ... urgent need for health care reform in the ... the National Association of Health Underwriters, the California ...
... dose delivered by cardiac CT angiography by 39% in adult ... performed at the University of Erlangen in Erlangen, Germany. ... or less, who underwent cardiac CT angiography either using a ... that the effective radiation dose for patients scanned with 120 ...
... The U.S. Patent and Trademark Office is reviewing ... to use saliva as a non-invasive way to ... undergo transplants. , Associate Professor of Pharmacy Fatemeh ... measure levels of immunosuppressive agents such as cyclosporine, ...
... environment in which hospital budgets are tight, debts ... Information Systems (SIS) continues to invest in perioperative ... reduce costs, improve patient safety and ensure compliance.(Logo: ... )The current economic downturn is making it extremely ...
Cached Medicine News:Health News:Access to Osteoporosis Testing for Americans in Jeopardy 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 3Health News:Access to Osteoporosis Testing for Americans in Jeopardy 4Health News:Access to Osteoporosis Testing for Americans in Jeopardy 5Health News:Acclaimed New England Photographer Donald Verger Holds 'Faces of Innocence' Charity Event for the Innocence Project 2Health News:Patent pending for pain-free method of monitoring drug levels in transplant patients 2Health News:SIS Continues to Innovate and Maintain Focus on Interoperability 2Health News:SIS Continues to Innovate and Maintain Focus on Interoperability 3
For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....
The Definitive automated slide stainer is an industry standard. The Definitive allows automated slide staining in a compact, self-contained and easy-to use package....
... is an "assembly-line worker" for routine staining ... laboratories. Programmable continuous slide stainer for routine ... slides in short time. Its large number ... continuous working principle provides a high throughput. ...
HMS 760 Robot Stainer. Version includes display....
Medicine Products: